WHO ICTRP trial
Opicapone in clinical practice (OPTIPARK)
EUCTR2016-002391-27-GB · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2016-002391-27-GB |
|---|---|
| Public title | Opicapone in clinical practice (OPTIPARK) |
| Scientific title | This action will amend the information submitted in this data field for all relevant applications. Please refer to the guidance under the Amendment tab and consider whether further notification to review bodies is required. - Opicapone in clinical practice (OPTIPARK)_V1 |
| Primary sponsor | BIAL - Portela & Ca, S.A. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes |
| Countries | Germany;United Kingdom |
| Conditions | Parkinson's disease (PD) patients with wearing-off motor fluctuations MedDRA version: 20.0 Level: PT Classification code 10061536 Term: Parkinson's disease System Organ Class: 10029205 - Nervous system disorders MedDRA version: 20.0 Level… |
| Interventions | Trade Name: Ongentys Product Name: Ongentys Pharmaceutical Form: Capsule, hard |
| Registration date | Apr 8, 2016 |
| Target size | 550 |
| Secondary IDs | BIA-OPC-401;NCT02847442 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: